🇺🇸
A court finding that Yutrepia infringed two valid claims of United Therapeutics’ ‘327 patent has put the drug’s PH-ILD indication and broader availability at risk. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of Liquidia…
Source: prnewswire
Country: United States